{
    "accessibility": "Open access",
    "additionDate": "2024-03-22T12:04:29.807254Z",
    "biotoolsCURIE": "biotools:fusionneoantigen",
    "biotoolsID": "fusionneoantigen",
    "confidence_flag": "tool",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "Pora.Kim@uth.tmc.edu",
            "name": "Pora Kim",
            "orcidid": "https://orcid.org/0000-0002-8321-6864",
            "typeEntity": "Person"
        },
        {
            "name": "Himansu Kumar",
            "typeEntity": "Person"
        }
    ],
    "description": "Resource of fusion gene-specific neoantigens.",
    "editPermission": {
        "type": "public"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Coding region prediction",
                    "uri": "http://edamontology.org/operation_0436"
                },
                {
                    "term": "Peptide immunogenicity prediction",
                    "uri": "http://edamontology.org/operation_0252"
                },
                {
                    "term": "Subcellular localisation prediction",
                    "uri": "http://edamontology.org/operation_2489"
                },
                {
                    "term": "Virtual screening",
                    "uri": "http://edamontology.org/operation_3938"
                }
            ]
        }
    ],
    "homepage": "https://compbio.uth.edu/FusionNeoAntigen",
    "lastUpdate": "2024-03-22T12:04:29.810128Z",
    "name": "FusionNeoAntigen",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1093/NAR/GKAD922",
            "metadata": {
                "abstract": "Among the diverse sources of neoantigens (i.e. single-nucleotide variants (SNVs), insertions or deletions (Indels) and fusion genes), fusion gene-derived neoantigens are generally more immunogenic, have multiple targets per mutation and are more widely distributed across various cancer types. Therefore, fusion gene-derived neoantigens are a potential source of highly immunogenic neoantigens and hold great promise for cancer immunotherapy. However, the lack of fusion protein sequence resources and knowledge prevents this application. We introduce ‘FusionNeoAntigen’, a dedicated resource for fusion-specific neoantigens, accessible at https://compbio.uth.edu/FusionNeoAntigen. In this resource, we provide fusion gene breakpoint crossing neoantigens focused on ∼43K fusion proteins of ∼16K in-frame fusion genes from FusionGDB2.0. FusionNeoAntigen provides fusion gene information, corresponding fusion protein sequences, fusion breakpoint peptide sequences, fusion gene-derived neoantigen prediction, virtual screening between fusion breakpoint peptides having potential fusion neoantigens and human leucocyte antigens (HLAs), fusion breakpoint RNA/protein sequences for developing vaccines, information on samples with fusion-specific neoantigen, potential CAR-T targetable cell-surface fusion proteins and literature curation. FusionNeoAntigen will help to develop fusion gene-based immunotherapies. We will report all potential fusion-specific neoantigens from all possible open reading frames of ∼120K human fusion genes in future versions.",
                "authors": [
                    {
                        "name": "Kim P."
                    },
                    {
                        "name": "Kumar H."
                    },
                    {
                        "name": "Luo R."
                    },
                    {
                        "name": "Wen J."
                    },
                    {
                        "name": "Yang C."
                    },
                    {
                        "name": "Zhou X."
                    }
                ],
                "citationCount": 1,
                "date": "2024-01-05T00:00:00Z",
                "journal": "Nucleic Acids Research",
                "title": "FusionNeoAntigen: a resource of fusion gene-specific neoantigens"
            },
            "pmcid": "PMC10767944",
            "pmid": "37870454"
        }
    ],
    "toolType": [
        "Database portal"
    ],
    "topic": [
        {
            "term": "Epigenetics",
            "uri": "http://edamontology.org/topic_3295"
        },
        {
            "term": "Gene transcripts",
            "uri": "http://edamontology.org/topic_3512"
        },
        {
            "term": "Immunogenetics",
            "uri": "http://edamontology.org/topic_3930"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        },
        {
            "term": "Small molecules",
            "uri": "http://edamontology.org/topic_0154"
        }
    ]
}
